60429 839 01
Nitroglycerin Tablet
Product Images NDC 60429-841
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nitroglycerin (NDC 60429-841). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
60429 839lb
This is a description of a medication containing 0.3 mg nitroglycerin in each tablet, with instructions to keep it away from children and to close it tightly after use to prevent loss of potency. It's not recommended to crush, chew or swallow the tablets, and it comes with a patient package insert. The lot number and expiration date are also provided, and the medication is manufactured by Ingenus Pharmaceuticals in Fairfield, NJ and packaged by GSMS, Incorporated.*
60429 840 04cn
60429 840 25lb
60429 841 01
This is the prescribing information for Nitroglycerin Sublingual Tablets. Each tablet contains 0.6 mg nitroglycerin. The usual dosage is provided along with the warning of feeling a "burning or tingling" sensation at the site of tablet placement, and that lack of “burning or tingling” does not indicate failure of Nitroglycerin release. If the pain persists or is different, prompt medical attention is recommended. Additionally, it is mentioned to keep the tablets in their original container and not to crush, chew, or swallow them. It also provides the NDC code and advises to store the tablets at 20-25°C (68-77°F) [see USP Controlled Room Temperature].*
60429 841 01lb
It is a package of 100 sublingual tablets of nitroglycerin (0.6 mg per tablet) manufactured by Ingenus Pharmaceuticals NJ, LLC and packaged by GSMS, Incorporated. The tablets should be kept at a temperature of 20-25°C (68°-77°F) and should not be crushed, chewed or swallowed. The package insert should be consulted for dosage information. The medication should be kept out of reach of children and the tablets should be closed tightly immediately after each use to prevent loss of potency. The lot number is GS029010 and the expiration date is 03/2021.*
Structure (Structure)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
